Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Study of Sitravatinib and Nivolumab in Urothelial Carcinoma

Multiple Cancer Types

The study will evaluate the clinical activity of nivolumab in combination with the investigational agent sitravatinib in patients with advanced or metastatic urothelial carcinoma.
Bladder, Urologic
II
Davis, Nancy
NCT03606174
VICCURO18175

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: